Gene therapy for neurologic disease: benchtop discoveries to bedside applications. 2. The bedside

scientific article

Gene therapy for neurologic disease: benchtop discoveries to bedside applications. 2. The bedside is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1177/088307389701200202
P698PubMed publication ID9075015

P2093author name stringM I Phillips
B L Maria
K B Hoang
C D Medina
P2860cites workConstitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytesQ28253669
Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transductionQ34354588
Suppression of human alpha-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectorsQ36362722
Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfataseQ36728931
Transfer of genes to humans: early lessons and obstacles to successQ40418899
Myoblast transfer and gene therapy in muscular dystrophiesQ40437473
Gene therapy and pharmacological treatment of inherited neurological disordersQ40535858
Gene therapy for solid tumorsQ40537219
Gene therapy and immune restoration for HIV diseaseQ40591308
Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritisQ40624060
Gene therapy for neurologic diseaseQ40769415
Gene therapy for neurologic disease: benchtop discoveries to bedside applications. 1. The benchQ41332176
Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovirQ41576545
Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vectorQ41590056
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainQ42280576
Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COL1A1) in transfected mouse 3T3 cellsQ42812729
A plasmid-based self-amplifying Sindbis virus vectorQ42824740
Direct gene transfer into nonhuman primate myofibers in vivoQ43851694
Human dystrophin expression corrects the myopathic phenotype in transgenic mdx miceQ45716447
Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for interventionQ45782573
Gene therapy for brain tumors in trials, correction of inherited disorders a hopeQ45875013
Preclinical studies of lymphocyte gene therapy for mild Hunter syndrome (mucopolysaccharidosis type II).Q45878645
Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctionsQ48283998
Human dystrophin expression in mdx mice after intramuscular injection of DNA constructsQ59080986
P433issue2
P921main subjectgene therapyQ213901
P304page(s)77-84
P577publication date1997-02-01
P1433published inJournal of Child NeurologyQ6294935
P1476titleGene therapy for neurologic disease: benchtop discoveries to bedside applications. 2. The bedside
P478volume12

Reverse relations

cites work (P2860)
Q34108056Gene therapy for brain tumors
Q34052329Genetic basis of intramedullary spinal cord tumors and therapeutic implications

Search more.